Teva Pharmaceutical Industries Limited - AnnualReports.com
DEFA14A
Fourth Quarter 2019 Results
Teva Pharmaceutical Industries Ltd. Company Profile - Market.us
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
DEF 14A
Teva Pharmaceutical Industries Limited - AnnualReports.com
Teva's 1st-qtr sales down, mainly hit by Copaxone competition
Form 10-K
TEVA PHARMACEUTICAL INDUSTRIES LTD Form 10-K Annual Report Filed 2019-02-19
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Goodwill By Year And By Quarter
Teva Has Turned the Corner - GuruFocus.com
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
Teva shares rise as company offers reassurance on former flagship drug Copaxone - MarketWatch
Teva, Mylan: Desperate Times Call For Desperate Measures (NYSE:TEVA) | Seeking Alpha
Why Teva Pharmaceutical Is Substantially More (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical net income 2006-2022 | Statista
Drug Stock Due for Another Climb on the Charts
Teva Announces New Environmental, Social and Governance (ESG) Strategy and Goals in 2020 Report | Business Wire
DEF 14A
Teva unloads plant, U.S. OTC line to PL Developments | Fierce Pharma
Teva Pharmaceutical Industries Limited - AnnualReports.com
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
DEFA14A
Teva Pharmaceutical Industries Limited - AnnualReports.com
